AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$413M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$335M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$311M |
| 5 |
Microsoft
MSFT
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$260M |
| 2 |
Medtronic
MDT
|
+$239M |
| 3 |
T-Mobile US
TMUS
|
+$221M |
| 4 |
CELG
Celgene Corp
CELG
|
+$204M |
| 5 |
Nike
NKE
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Financials | 15.59% |
| 3 | Healthcare | 14.73% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PINC
2276
DELISTED
Premier
PINC
| $1.1M | ﹤0.01% |
28,014
-5,415
| -16% | -$196K |
|
|
VIVO
2277
DELISTED
Meridian Bioscience Inc
VIVO
| $1.1M | ﹤0.01% |
92,237
+17,300
| +23% | +$208K |
|
2278
MacroGenics
MGNX
$235M
| $1.09M | ﹤0.01% |
64,500
+22,800
| +55% | +$392K |
|
2279
Parsons
PSN
$4.72B
| $1.09M | ﹤0.01% |
+29,700
| New | +$973K |
|
|
PVLA
2280
Palvella Therapeutics
PVLA
$1.99B
| $1.09M | ﹤0.01% |
2,905
+103
| +4% | +$30.7K |
|
|
NSTG
2281
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.09M | ﹤0.01% |
35,900
+11,300
| +46% | +$299K |
|
2282
QuinStreet
QNST
$890M
| $1.08M | ﹤0.01% |
68,300
+29,100
| +74% | +$434K |
|
2283
Globant
GLOB
$1.58B
| $1.08M | ﹤0.01% |
10,710
| – | – |
|
2284
Gildan
GIL
$10.3B
| $1.07M | ﹤0.01% |
27,619
+1,768
| +7% | +$66K |
|
2285
Upwork
UPWK
$1.13B
| $1.06M | ﹤0.01% |
66,100
+50,700
| +329% | +$874K |
|
|
CGC
2286
Canopy Growth
CGC
$387M
| $1.06M | ﹤0.01% |
2,631
+832
| +46% | +$366K |
|
|
SEMG
2287
DELISTED
SEMGROUP CORPORATION
SEMG
| $1.06M | ﹤0.01% |
88,298
-41
| -0% | -$543 |
|
|
NVEE
2288
DELISTED
NV5 Global
NVEE
| $1.06M | ﹤0.01% |
52,000
-39,444
| -43% | -$704K |
|
|
MODV
2289
DELISTED
ModivCare
MODV
| $1.06M | ﹤0.01% |
18,423
+4,500
| +32% | +$292K |
|
|
LABL
2290
DELISTED
Multi-Color Corp
LABL
| $1.05M | ﹤0.01% |
21,100
+5,700
| +37% | +$285K |
|
2291
Anika Therapeutics
ANIK
$258M
| $1.05M | ﹤0.01% |
25,800
+4,400
| +21% | +$160K |
|
2292
Columbia Financial
CLBK
$1.12B
| $1.05M | ﹤0.01% |
69,300
-600
| -0.9% | -$9.22K |
|
2293
Axogen
AXGN
$2.27B
| $1.04M | ﹤0.01% |
52,600
+1,800
| +4% | +$38.5K |
|
2294
Camden National
CAC
$978M
| $1.04M | ﹤0.01% |
22,675
+400
| +2% | +$17.5K |
|
2295
Carvana
CVNA
$68.6B
| $1.04M | ﹤0.01% |
82,750
-130,250
| -61% | -$1.67M |
|
|
SWI
2296
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.04M | ﹤0.01% |
53,555
+30,582
| +133% | +$601K |
|
2297
Myers Industries
MYE
$1.29B
| $1.03M | ﹤0.01% |
53,700
+25,400
| +90% | +$457K |
|
|
DRNA
2298
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.03M | ﹤0.01% |
65,600
+7,700
| +13% | +$105K |
|
2299
Stock Yards Bancorp
SYBT
$2.64B
| $1.03M | ﹤0.01% |
28,514
+500
| +2% | +$17.3K |
|
2300
Theravance Biopharma
TBPH
$874M
| $1.03M | ﹤0.01% |
62,935
| – | – |
|
Similar funds
AllianceBernstein's Q2 2019 Portfolio in Review
As of Q2 2019, AllianceBernstein held 3,270 positions worth $161B, up 4.8% from $154B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AllianceBernstein's Q2 2019 filing shows 163 new, 1,818 increased, 1,043 reduced and 130 closed positions. Its largest new stake was Smartsheet Inc.: 1,910,302 shares worth $92.5M. The largest sale was Apple, an estimated $260M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q2 2019 buy was Smartsheet Inc.: 1,910,302 shares worth $92.5M.
- AllianceBernstein added most to UnitedHealth in Q2 2019, an estimated $413M increase.
- AllianceBernstein's biggest Q2 2019 reduction was Apple, cutting an estimated $260M.
- AllianceBernstein fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2019, selling an estimated $177M.
- AllianceBernstein's ten largest holdings make up 18% of its $161B portfolio in Q2 2019.
- AllianceBernstein opened 163 new positions and closed 130 in Q2 2019.
- AllianceBernstein's portfolio value rose 4.8% quarter-over-quarter to $161B.
Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.